Apervita Completes $18M Series A Round of Funding

apervita_styleguide_v2Apervita, Inc. (formerly known as Pervasive Health, Inc.), a Chicago, Illinois-based health analytics marketplace, completed an $18m Series A round of funding.

The round was led by GE Ventures and Baird Capital with participation from Pritzker Group Venture Capital, Math Ventures and existing investors.

The company intends to use the funds to accelerate the development of its platform, and to expand sales and marketing team to promote the platform.

Led by Paul Magelli, founder and CEO, Apervita provides a secure and HIPAA–compliant cloud platform that enables authors to share their evidence-based research as computable insights and publish them to a marketplace, allowing users to subscribe, and connect them to their workflow.  Its repository of analytics includes evidenced-based content from top academic medical centers, such as Mayo Clinic. They address many fundamental provider challenges in areas that include chronic disease management, preventable adverse events, readmissions, cancer, early warning, quality and safety. The portfolio will soon expand to include operational and financial areas as well.



Join the discussion